Cite

HARVARD Citation

    Keshvari, M. et al. (2022). 027  Eosinophilia and lymphocytosis after natalizumab for relapsing-remitting multiple sclerosis. Journal of neurology, neurosurgery and psychiatry. 93 (6), p. A22. [Online]. 
  
Back to record